As pharmaceutical companies have grown and globalized, they have faced increased challenges to sustain innovation with global teams and to be nimble and stay ahead of ever more diverse competitors. They are constantly challenged to accelerate the process of bringing new drugs to the market that are medically effective and differentiated from the competition. While trying to meet these challenges, they must continuously manage the very difficult balance between market driven "need for speed" and the absolute need for scientific rigor and safety.

The challenges are great, and the answers lie in leadership and team development. In the recent issue of Future Pharma magazine, Andy Atkins and Jamie Harris collaborated on an article entitled, "The Leadership Enterprise," that shows how. To read it, download it here.